162 related articles for article (PubMed ID: 15134556)
1. Intravenous glycoprotein IIb/IIIa antagonists: their benefits, problems and future developments.
Curtin R
Curr Pharm Des; 2004; 10(14):1577-85. PubMed ID: 15134556
[TBL] [Abstract][Full Text] [Related]
2. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
Silva MA; Donovan JL; Gandhi PJ; Volturo GA
Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468
[TBL] [Abstract][Full Text] [Related]
3. Oral GPIIb/IIIa antagonists: what went wrong?
Cox D
Curr Pharm Des; 2004; 10(14):1587-96. PubMed ID: 15134557
[TBL] [Abstract][Full Text] [Related]
4. Platelet glycoprotein IIb/IIIa inhibition and its clinical use.
Huang F; Hong E
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jul; 2(3):187-96. PubMed ID: 15320785
[TBL] [Abstract][Full Text] [Related]
5. [The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
Galli M; Maggioni AP; Vassanelli C; Tavazzi L
Ital Heart J Suppl; 2000 Feb; 1(2):202-11. PubMed ID: 10731377
[TBL] [Abstract][Full Text] [Related]
6. Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.
De Luca G; Savonitto S; van't Hof AW; Suryapranata H
Drugs; 2015 Jul; 75(11):1229-53. PubMed ID: 26177890
[TBL] [Abstract][Full Text] [Related]
7. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.
Dyke CM
Am Heart J; 1999 Oct; 138(4 Pt 2):307-16. PubMed ID: 10502236
[TBL] [Abstract][Full Text] [Related]
8. Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.
Vorchheimer DA; Badimon JJ; Fuster V
JAMA; 1999 Apr; 281(15):1407-14. PubMed ID: 10217057
[TBL] [Abstract][Full Text] [Related]
9. Anti-platelet therapy: glycoprotein IIb-IIIa antagonists.
Schneider DJ
Br J Clin Pharmacol; 2011 Oct; 72(4):672-82. PubMed ID: 21906121
[TBL] [Abstract][Full Text] [Related]
10. Risks and benefits of glycoprotein IIb/IIIa antagonists in acute coronary syndrome.
Latour-Pérez J
Ann Pharmacother; 2001 Apr; 35(4):472-9. PubMed ID: 11302412
[TBL] [Abstract][Full Text] [Related]
11. Oral glycoprotein IIb/IIIa antagonists in coronary artery disease.
Chew DP; Bhatt DL
Curr Cardiol Rep; 2001 Jan; 3(1):63-71. PubMed ID: 11139801
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: where are we now?
Maree A; Fitzgerald DJ
Semin Vasc Med; 2003 Nov; 3(4):385-90. PubMed ID: 15199445
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of glycoprotein IIb/IIIa-receptor inhibitors during percutaneous coronary intervention.
Cheng JW
Am J Health Syst Pharm; 2002 Nov; 59(21 Suppl 7):S5-14. PubMed ID: 12434710
[TBL] [Abstract][Full Text] [Related]
14. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Bhatt DL; Topol EJ
JAMA; 2000 Sep; 284(12):1549-58. PubMed ID: 11000650
[TBL] [Abstract][Full Text] [Related]
15. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
Harrington RA
Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
[TBL] [Abstract][Full Text] [Related]
16. [Use of platelet glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndrome and coronary intervention].
Kakuta T; Kishi Y; Numano F
Nihon Rinsho; 1998 Oct; 56(10):2630-4. PubMed ID: 9796330
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: pathophysiologic foundation and clinical findings.
Kleiman NS; Lincoff AM; Ohman EM; Harrington RA
Am Heart J; 1998 Oct; 136(4 Pt 2 Su):S32-42. PubMed ID: 9778086
[TBL] [Abstract][Full Text] [Related]
18. Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (ICE) Trial.
Deibele AJ; Jennings LK; Tcheng JE; Neva C; Earhart AD; Gibson CM
Circulation; 2010 Feb; 121(6):784-91. PubMed ID: 20124127
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy of platelet IIb/IIIa receptor blockers in acute coronary syndromes].
Sitges M; Bosch X; Sanz G
Rev Esp Cardiol; 2000 Mar; 53(3):422-39. PubMed ID: 10712972
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
